Son güncelleme :
08/05/2024
Vazodilatör   Alprostadil  
Enjeksiyon
Çözeltilerin stabilitesi Karışımlardaki stabilitesi Stabiliteyi etkileyen faktörler Uyumluluk Uygulama yöntemi Kaynaklar Pdf
   Kimyasal yapı   

Ticari isim   Ticari isim     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfaprostin Mısır
Alistint Peru
Alpros Türkiye
Alprostadil Almanya, Amerika Birleşik Devletleri, Arjantin, Ekvador, İspanya, Kanada, Malezya, Peru, Romanya, Şili, Türkiye
Alprostapint Arjantin, Avusturya, Ekvador, Kolombiya, Macaristan, Peru
Alprostar İtalya
Aplicav Brezilya
Cardiobon Arjantin, Peru
Caverject Amerika Birleşik Devletleri, Avusturya, Belçika, Brezilya, Büyük Britanya, Danimarka, Fransa, Güney Afrika Cumhuriyeti, İspanya, İsveç, İsviçre, İtalya, Kanada, Norveç, Polonya, Portekiz, Slovenya, Türkiye
Edex Fransa
Liple Japonya
Minprog Almanya, Avusturya
Ostapint Meksika, Peru
Palux Japonya
Pridax Almanya, Avusturya, İspanya, Romanya
Prolisina VR Arjantin
Prostandin Japonya
Prostavasin Almanya, Avusturya, İran, İtalya, Lüksemburg, Macaristan, Mısır, Polonya
Prostin VR Amerika Birleşik Devletleri, Avustralya, Belçika, Büyük Britanya, Danimarka, Finlandiya, Hollanda, İran, İsviçre, İtalya, Kanada, Lüksemburg, Macaristan, Malezya, Norveç, Polonya, Portekiz, Suudi Arabistan, Venezuela, Yunanistan
Prostine VR Fransa
Vasaprostan Romanya
Kaynaklar   Enjeksiyon    Kaynaklar : Alprostadil  
Tip Yayın
1072 Dergi Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1899 Dergi Trissel LA, Zhang Y.
Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Int J Pharm Compound 2004 ; 8, 3: 231-235.
2003 Dergi Paul M, Razzouq N, Tixier G, Astier A.
Stability of prostaglandin E1 (PGE1) in aqueous solutions.
EJHP Science 2005 ; 2: 31-36.
2090 Dergi Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
2150 Dergi Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G.
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
J Urology 1998 ; 160; 2: 551-555.
2151 Dergi Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F.
Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC).
Int J Pharm 1995 ; 115: 113-117.
3201 Dergi Dice JE.
Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit.
J Pediatr Pharmacol Ther 2006 ; 11:233?6.
3448 Dergi Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Ann Pharm Fr 2013 ; 71, 5: 358-363.
3761 Kitap Chavan E.
Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie.
Master en pharmacie - University of Geneva 2014
3961 Dergi McCluskey S.V,Kirkham K,Munson J.M.
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers.
Int J Pharm Compound 2017 ; 21, 2: 150-153.
4069 Dergi Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F.
Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns.
EJHP 2018 ; 25, e2
4389 Dergi Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4491 Dergi De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2020
4507 Dergi Ross E, Salinas A, Petty K, Her C, Carpenter J.
Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing.
Am J Health-Syst Pharm 2020 ;77,23:1980-1985
4543 Dergi Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4570 Dergi Greenhill K, Hornsby E, Gorman G.
Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
Pharmaceuticals 2019
4651 Dergi De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2021 ;180,1169–1176.

  Mentions Légales